PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹416 Cr | ₹367 Cr | ₹369 Cr | ₹656 Cr | ₹368 Cr |
What is the latest Contingent Liabilities ratio of PANACEA BIOTEC ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹416 Cr |
| Mar2025 | ₹367 Cr |
| Mar2024 | ₹369 Cr |
| Mar2023 | ₹656 Cr |
| Mar2022 | ₹368 Cr |
How is Contingent Liabilities of PANACEA BIOTEC Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹416 Cr | 13.45 | |
| Mar2025 | ₹367 Cr | -0.62 | |
| Mar2024 | ₹369 Cr | -43.67 | |
| Mar2023 | ₹656 Cr | 78.11 | |
| Mar2022 | ₹368 Cr | - | |
Compare Contingent Liabilities of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,141.5 Cr | -5% | -8.6% | -11.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,562.0 Cr | -3.2% | -7.8% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,572.0 Cr | -3.3% | -0.2% | 63.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,871.0 Cr | -2.4% | -5% | 33.6% | Stock Analytics | |
| CIPLA | ₹107,770.0 Cr | -4% | -5.6% | -10.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,829.0 Cr | -1.2% | 4.1% | -4.2% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | -5% |
-8.6% |
-11.5% |
| SENSEX | -2.1% |
-5.9% |
-10.8% |
You may also like the below Video Courses